HRS: Rhythm, not regulation
By Merrill Goozner ProPublica, the online investigative website, carried a revealing set of stories Thursday documenting the financial ties between the Heart Rhythm Society, which represents the...
View ArticleAdvaMed pushes for sunshine law implementation
"Sunlight is the best disinfectant," at least according to former U.S. Supreme Court Justice Louis Brandeis, and the medical device industry’s main lobbying group seems to agree. In a letter to U.S....
View ArticleMinnesota doc fails to report conflict of interest payments from Medtronic
The University of Minnesota Medical School sent a warning letter to spinal surgeon Dr. David Polly after he failed to disclose payments received from med-tech titan Medtronic (NYSE:MDT). Polly...
View ArticleU-Wisc. ortho chair Zdeblick under fire for $25M relationship with Medtronic
University of Wisconsin spinal surgeon Dr. Thomas Zdeblick is in the hot seat over a running tab with med-tech titan Medtronic Inc. (NYSE:MDT) that’s topped $25 million since 2003. During that time,...
View ArticleThe law of unintended consequences: Transparency rules may harm sickest...
MASSDEVICE ON CALL — A new study out of Brigham & Women’s Hospital in Boston suggests that transparency rules might have negative consequences for very sick heart patients. The study evaluated the...
View ArticleMassDevice.com +3 | The top 3 med-tech stories for June 20, 2013
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleDo public reports put patients 2nd to a hospital’s reputation? |...
MASSDEVICE ON CALL — Doctors at publicly reported hospitals may be negatively influenced by public reporting protocols, according to a presentation at last week’s Society for Cardiovascular...
View ArticleOpenFDA: Innovative initiative opens door to wealth of FDA’s publicly...
By: Taha A. Kass-Hout, M.D., M.S. Today, I am pleased to announce the launch of openFDA, a new initiative from our Office of Informatics and Technology Innovation (OITI). OpenFDA is specifically...
View ArticleNo more secrecy in medtech pricing, says Sen. King
(Transcript below) Senator Angus King (I-Maine) has a new bill on the floor that he says will correct a fundamental imbalance in the medtech market, namely by imposing more pricing transparency on...
View Article
More Pages to Explore .....